{
    "clinical_study": {
        "@rank": "83927", 
        "acronym": "CINNAMOME", 
        "arm_group": {
            "arm_group_label": "Surgery", 
            "arm_group_type": "Other", 
            "description": "sentinel node biopsy and mastectomy"
        }, 
        "brief_summary": {
            "textblock": "The rate of axillary dissection avoided in patients with Ductal Carcinoma in Situ (DCIS) and\n      a mastectomy indication will be obtained by calculating the proportion of women with GAS\n      in-patient population that will prove to be DCIS or DCIS-MI + CCI. A confidence interval of\n      95% will be deferred."
        }, 
        "brief_title": "Management of Ductal Carcinoma in Situ or Pure Micro-invasive Extended Breast", 
        "completion_date": {
            "#text": "December 2010", 
            "@type": "Actual"
        }, 
        "condition": "Intraductal Carcinoma and Lobular Carcinoma in Situ", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Carcinoma in Situ", 
                "Carcinoma, Intraductal, Noninfiltrating", 
                "Carcinoma, Lobular", 
                "Carcinoma, Ductal, Breast", 
                "Carcinoma, Ductal"
            ]
        }, 
        "detailed_description": {
            "textblock": "The rate of axillary dissection avoided in patients with DCIS and a mastectomy indication\n      will be obtained by calculating the proportion of women with GAS in-patient population that\n      will prove to be DCIS or DCIS-MI + CCI (after the final histology). A confidence interval of\n      95% will be deferred (binomial).\n\n      The rate of axillary dissection avoided in patients with DCIS-MI and an indication of\n      mastectomy is obtained by calculating the proportion of women with a GAS-all women with\n      DCIS-MI and an indication of mastectomy. A confidence interval of 95% will be deferred\n      (binomial)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Older than 18 years.\n\n          -  Preoperative histological diagnosis obtained by biopsy\n\n          -  Ductal carcinoma in situ (DCIS) or pure micro-invasive (DCIS-MI)\n\n          -  Indication of mastectomy\n\n          -  Patient signed informed consent\n\n        Exclusion Criteria:\n\n          -  Age < 18 years\n\n          -  Infiltrating ductal carcinoma (TCC) diagnosed on biopsy\n\n          -  Pure DCIS diagnosed by lumpectomy\n\n          -  DCIS can take a conservative treatment\n\n          -  Mastectomy chosen by the patient\n\n          -  History of breast carcinoma in situ or invasive ipsilateral\n\n          -  Prior radiotherapy to the ipsilateral breast\n\n          -  History of axillary lateral homo\n\n          -  Patient who for reasons psychological, social, family or geographical could not be\n             treated or monitored regularly according to the criteria of the study\n\n          -  Patient deprived of liberty or under guardianship"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "231", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 5, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01841749", 
            "org_study_id": "IB2007-40"
        }, 
        "intervention": {
            "arm_group_label": "Surgery", 
            "description": "sentinel node biopsy and mastectomy", 
            "intervention_name": "sentinel node biopsy and mastectomy", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Breast cancer", 
        "lastchanged_date": "April 23, 2013", 
        "link": {
            "description": "Site internet du promoteur, l'Institut Bergoni\u00e9", 
            "url": "http://www.bergonie.org/fr/essais-clinique.html"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Bordeaux", 
                    "country": "France", 
                    "state": "Aquitaine", 
                    "zip": "33000"
                }, 
                "name": "Institut Bergoni\u00e9"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Management of Ductal Carcinoma in Situ (DCIS) or Pure Micro-invasive (DCIS-MI) Extended Breast, Axillary Node Sentinel Site (GAS) When the Diagnosis is Made by Biopsy and Treatment by Mastectomy Immediately. Descriptive Study", 
        "overall_official": {
            "affiliation": "Institut Bergoni\u00e9", 
            "last_name": "TUNON DE LARA Christine, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Highlight the interest of GAS associated with a mastectomy immediately in pure ductal carcinoma in situ (DCIS) and micro-infiltrating (DCIS-MI) with indication of mastectomy in estimating the rate of axillary dissection avoided due a GAS-detected", 
            "measure": "Highlight the contribution of sentinel node associated with a mastectomy immediately in pure ductal carcinoma in situ (DCIS) and micro-invasive (DCIS-MI)", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01841749"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Number and rate of axillary dissection performed immediately during the mastectomy following the discovery of a GAS +, having avoided a surgical procedure later;\nrate of discordance between biopsy and histology final;\ndetection rate of sentinel axillary lymph nodes (GAS), regardless of nodal status;\nGAS positive rate in the population of patients in whom the GAS has been detected.\n200 patients: 100 patients with a biopsy showing DCIS and an indication of mastectomy and 100 patients with a biopsy showing DCIS-MI and an indication of mastectomy", 
            "measure": "Among women with ductal carcinoma in situ pure (DCIS) and micro-infiltrating (DCIS-MI) and indication of mastectomy", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "source": "Institut Bergoni\u00e9", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Institut Bergoni\u00e9", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2008", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}